Abstract:This study was done to prepare thymopentin (TP5)-loaded poly (butyl cyanoacrylate) nanoparticles (TP5-PBCA-NPs) and evaluate thier efficacy for oral delivery. TP5-PBCA-NPs were prepared by emulsion polymerization, and the formulation was optimized based on Box-Behnken experimental design. The physico-chemical characteristics of TP5-PBCA-NPs were evaluated using transmission electron microscopy (TEM), malvern zetasizer, Fourier transform infra-red spectroscopy (FT-IR) and differential scanning calorimetry (DSC). The encapsulation efficiency, enzymatic degradation and release behavior of TP5-PBCA-NPs in various media were evaluated using a high-performance liquid chromatography (HPLC) method. The pharmacodynamic studies on oral administration of TP5-PBCA-NPs were performed in FACScan flow cytometry. An optimum formulation consisted of 0.7% poloxamer 188 (Pol), 0.6% dextran-70 (Dex), 0.1% sodium metabisulfite (Sm), 0.1% TP5 and 1% (v/v) n-butyl cyanoacrylate. The particle size and zeta potential of optimized TP5-PBCA-NPs was 212 nm and -22.6 mV respectively with 82.45% encapsulation efficiency. TP5 was entrapped inside the nanoparticles in molecular dispersion form. The release of TP5 from PBCA-NPs was pH dependent; the cumulative release percentage in 0.1 M HCI for 4 hours was less than 16% while it was more than 80% in pH6.8 PBS. The PBCA-NPs could efficiently protect TP5 from enzymatic degradation; the remained percentage of TP5 encapsulated in PBCA-NPs was 58.40% after incubated with trypsin in pH6.8 PBS for 4 h while it was only 32.29% for free drug. In the oral administration study in vivo, the lowered T-lymphocyte subsets values were significantly increased and the raised CD4+/CD8+ ratio was evidently reduced compared with that of TP5 solution (p < 0.05), and the improvement of bioavailability was dose-dependent. These results indicated that the PBCA nanoparticles may be a promising carrier for oral delivery of TP5.

Synthesis of site-specific PEGylated thymopentin

Using liquid phase synthesis and solid-phase synthesis techniques to prepare pegylated thymopentin

N-terminal Site-Specific PEGylation Enhances the Circulation Half-Life of Thymosin Alpha 1

Kinetic Optimization and Scale-Up of Site-Specific Thiol-PEGylation of Loxenatide from Laboratory to Pilot Scale

Characterization of a site-specific PEGylated analog of exendin-4 and determination of the PEGylation site.

Site-Directed Modification of Genetically Engineered Proteus Sp Lipase K107 Variants with A Polyethylene Glycol Derivative

Bioactivities and Enzymatic Degradation in Vitro of Peglated Thymopentin

Site-directed Polyethylene Glycol Modification of Trichosanthin

Site-specific N-terminal PEGylation-based controlled release of biotherapeutics: An application for GLP-1 delivery to improve pharmacokinetics and prolong hypoglycemic effects

Thymopentin Nanoparticles Engineered with High Loading Efficiency, Improved Pharmacokinetic Properties, and Enhanced Immunostimulating Effect Using Soybean Phospholipid and PHBHHx Polymer.

Trypsin‐Catalyzed Kinetically Controlled Synthesis of a Precursor Dipeptide of Thymopentin in Organic Solvents, Using a Free Amino Acid As Nucleophile

Scalable Preparation of Green C-terminal Amidation Peptide-Synthesis TAGs and the Optimized TAG-assisted Liquid-Phase Synthesis of Eptifibatide

Expression of Thymosin Α1-Thymopentin Fusion Peptide in Pichia Pastoris and Its Characterization

Expression, Purification, and C-terminal Site-Specific PEGylation of Cysteine-Mutated Glucagon-Like Peptide-1

Site-specific PEGylation Strategies and Suitable Modified Sites of Protein Drugs

Thymopentin-loaded pH-sensitive chitosan nanoparticles for oral administration: preparation, characterization, and pharmacodynamics.

[A comparative study on the properties of trichosanthin before and after site-directed PEGylation].

Oxidized catechol-derived poly (ethylene glycol) for thiol-specific conjugation

Solid-Phase Synthesis of Thymopentin Using Fmoc-Based Strategy

Box-Behnken Optimization Design and Enhanced Oral Bioavailability of Thymopentin-Loaded Poly (butyl Cyanoacrylate) Nanoparticles

Combined Optimization of N-terminal Site-Specific PEGylation of Recombinant Hirudin Using Response Surface Methodology and Kinetic Analysis.